T A D'Ascoli1, J Mursu2, S Voutilainen2, J Kauhanen2, T-P Tuomainen2, J K Virtanen2. 1. Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. 2. Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.
Abstract
BACKGROUND/ OBJECTIVES: Fish intake and the long-chain omega-3 polyunsaturated fatty acids (PUFAs) in fish have been suggested to lower the risk of cognitive decline. We assessed whether serum long-chain omega-3 PUFAs eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) are associated with performance on neuropsychological tests in an older population and whether exposure to methylmercury, mainly from fish, or apolipoprotein-E4 (Apo-E4) phenotype can modify the associations. SUBJECTS/ METHODS: A total of 768 participants from the population-based Kuopio Ischaemic Heart Disease Risk Factor Study were included. Cognitive function was measured using five neuropsychological tests: the Trail Making Test, the Verbal Fluency Test, the Selective Reminding Test, the Visual Reproduction Test and the Mini Mental State Exam. Multivariate-adjusted analysis of covariance and linear regression were used to analyze the cross-sectional associations. RESULTS: We found statistically significant associations between serum EPA+DPA+DHA and better performance in the Trail Making Test and the Verbal Fluency Test. The individual associations with EPA and DHA were similar with the findings with EPA+DPA+DHA, although the associations with DHA were stronger. No associations were observed with serum DPA. Pubic hair mercury content was associated only with a worse performance in the Trail Making Test, and mercury had only little impact on the associations between the serum PUFAs and cognitive performance. Apo-E4 phenotype did not modify the associations with PUFAs or mercury. CONCLUSIONS: Higher serum long-chain omega-3 PUFA concentrations were associated with better performance on neuropsychological tests of frontal lobe functioning in older men and women. Mercury exposure or Apo-E4 phenotype had little impact on cognitive performance.
BACKGROUND/ OBJECTIVES: Fish intake and the long-chain omega-3 polyunsaturated fatty acids (PUFAs) in fish have been suggested to lower the risk of cognitive decline. We assessed whether serum long-chainomega-3 PUFAseicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) are associated with performance on neuropsychological tests in an older population and whether exposure to methylmercury, mainly from fish, or apolipoprotein-E4 (Apo-E4) phenotype can modify the associations. SUBJECTS/ METHODS: A total of 768 participants from the population-based Kuopio Ischaemic Heart Disease Risk Factor Study were included. Cognitive function was measured using five neuropsychological tests: the Trail Making Test, the Verbal Fluency Test, the Selective Reminding Test, the Visual Reproduction Test and the Mini Mental State Exam. Multivariate-adjusted analysis of covariance and linear regression were used to analyze the cross-sectional associations. RESULTS: We found statistically significant associations between serum EPA+DPA+DHA and better performance in the Trail Making Test and the Verbal Fluency Test. The individual associations with EPA and DHA were similar with the findings with EPA+DPA+DHA, although the associations with DHA were stronger. No associations were observed with serum DPA. Pubic hair mercury content was associated only with a worse performance in the Trail Making Test, and mercury had only little impact on the associations between the serum PUFAs and cognitive performance. Apo-E4 phenotype did not modify the associations with PUFAs or mercury. CONCLUSIONS: Higher serum long-chain omega-3 PUFA concentrations were associated with better performance on neuropsychological tests of frontal lobe functioning in older men and women. Mercury exposure or Apo-E4 phenotype had little impact on cognitive performance.
Authors: Jyrki K Virtanen; Sari Voutilainen; Tiina H Rissanen; Jaakko Mursu; Tomi-Pekka Tuomainen; Maarit J Korhonen; Veli-Pekka Valkonen; Kari Seppänen; Jari A Laukkanen; Jukka T Salonen Journal: Arterioscler Thromb Vasc Biol Date: 2004-11-11 Impact factor: 8.311
Authors: Edeltraut Kröger; René Verreault; Pierre-Hugues Carmichael; Joan Lindsay; Pierre Julien; Eric Dewailly; Pierre Ayotte; Danielle Laurin Journal: Am J Clin Nutr Date: 2009-05-27 Impact factor: 7.045
Authors: Henry A Roman; Tyra L Walsh; Brent A Coull; Éric Dewailly; Eliseo Guallar; Dale Hattis; Koenraad Mariën; Joel Schwartz; Alan H Stern; Jyrki K Virtanen; Glenn Rice Journal: Environ Health Perspect Date: 2011-01-10 Impact factor: 9.031
Authors: M Haution-Bitker; T Gilbert; A Vignoles; C Lecardonnel; S Watelet; E Blond; J Drai; M Bonnefoy Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Maija P T Ylilauri; Sari Hantunen; Eija Lönnroos; Jukka T Salonen; Tomi-Pekka Tuomainen; Jyrki K Virtanen Journal: Eur J Nutr Date: 2022-02-25 Impact factor: 4.865
Authors: Kristen L Lindenau; Jeffrey L Barr; Christopher R Higgins; Kevin T Sporici; Eugen Brailoiu; Gabriela C Brailoiu Journal: Int J Mol Sci Date: 2022-02-18 Impact factor: 5.923